Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis
The American Journal of Pathology · 2023
DOI: 10.1016/j.ajpath.2022.12.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2023. Verfasst von Kevin De Muynck und 13 weiteren Autor:innen. Beteiligte Einrichtung: Gut-Liver Immunopharmacology Unit, Department of Basic and Applied Medical Sciences, Liver Research Center Ghent, Ghent University, Ghent, Belgium; H…. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Cholestasis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek, Universiteit Gent, European Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Gut-Liver Immunopharmacology Unit, Department of Basic and Applied Medical Sciences, Liver Research Center Ghent, Ghent University, Ghent, Belgium; Hepatology Research Unit, Department of Internal Medicine and Pediatric…
- Department of Biomedical Molecular Biology, Faculty of Science, Ghent University, Ghent, Belgium; Laboratory of Myeloid Cell Biology in Tissue Damage and Inflammation, Vlaams Instituut voor Biotechnologie-UGent Center f…
- Gut-Liver Immunopharmacology Unit, Department of Basic and Applied Medical Sciences, Liver Research Center Ghent, Ghent University, Ghent, Belgium; Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Univer…
- Inflammatory Bowel Disease Research Unit, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium; Intestinal Barrier Signaling in Disease and Therapy, Vlaams Instituut voor Biotechnologie-UGent…
- Department of Biomedical Molecular Biology, Faculty of Science, Ghent University, Ghent, Belgium; Laboratory of Myeloid Cell Biology in Tissue Homeostasis and Regeneration, Vlaams Instituut voor Biotechnologie-UGent Cen…
- Cellular & Molecular Immunology Research Group, Vrije Universiteit Brussel, Brussels, Belgium; Myeloid Cell Immunology Lab, Vlaams Instituut voor Biotechnologie-Vrije Universiteit Brussel, Brussels, Belgium.
Förderung
- Fonds Wetenschappelijk Onderzoek
- Universiteit Gent
- European Research Council
Zitieren
APA
De Muynck, K., Vanderborght, B., De Ponti, F. F., Gijbels, E., Van Welden, S., Guilliams, M., Scott, C. L., Beschin, A., Vinken, M., Lefere, S., Geerts, A., Verhelst, X., Van Vlierberghe, H., & Devisscher, L. (2023). Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2022.12.008
Vancouver
De Muynck K, Vanderborght B, De Ponti FF, Gijbels E, Van Welden S, Guilliams M, et al. Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis. The American Journal of Pathology. 2023. doi:10.1016/j.ajpath.2022.12.008
BibTeX
@article{DeMuynck2023,
author = {De Muynck, Kevin and Vanderborght, Bart and De Ponti, Federico F and Gijbels, Eva and Van Welden, Sophie and Guilliams, Martin and Scott, Charlotte L and Beschin, Alain and Vinken, Mathieu and Lefere, Sander and Geerts, Anja and Verhelst, Xavier and Van Vlierberghe, Hans and Devisscher, Lindsey},
title = {Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis},
journal = {The American Journal of Pathology},
year = {2023},
doi = {10.1016/j.ajpath.2022.12.008}
}
EUVIMED